Clinical Trial Update: Anti-Malarial Drug Resistance in Cameroon [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial in Cameroon investigates anti-malarial drug resistance and has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 2, Phase 3 | Status: COMPLETED